Bill
Bill > SF163
summary
Introduced
01/29/2025
01/29/2025
In Committee
01/29/2025
01/29/2025
Crossed Over
Passed
Dead
Introduced Session
91st General Assembly
Bill Summary
This bill relates to the medical cannabidiol program. The bill changes the definition of “medical cannabidiol” to include specific forms of oral, topical, and inhalable cannabis.
AI Summary
This bill modifies the definition of medical cannabidiol (medical CBD) in Iowa's legal code by expanding the allowable forms of the substance. Specifically, the bill broadens the definition to include various forms of cannabis plant extracts and preparations that can be delivered through three primary methods: oral forms (such as tablets, capsules, liquids, tinctures, and sublingual preparations), topical forms (including gels, ointments, creams, lotions, and transdermal patches), and inhaled forms (limited to nebulizable inhaled forms, vaporizable dried raw cannabis, and other vaporizable cannabis forms). This comprehensive definition appears to provide more flexibility for medical cannabis patients by outlining a wider range of acceptable delivery methods for medical cannabidiol, which could potentially improve accessibility and treatment options for individuals seeking medical cannabis for therapeutic purposes.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Senate Health and Human Services Committee (09:30:00 3/5/2025 RM 116) (on 03/05/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.legis.iowa.gov/legislation/BillBook?ga=91&ba=SF163 |
| BillText | https://www.legis.iowa.gov/docs/publications/LGI/91/attachments/SF163.html |
Loading...